N
Natixis’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-500,000
| Closed | -$67.7M | – | 1069 |
|
|
2020
Q3 | $67.7M | Buy |
+500,000
| New | +$67.7M | 0.5% | 50 |
|
|
2019
Q4 | – | Sell |
-1,251,208
| Closed | -$125M | – | 892 |
|
|
2019
Q3 | $125M | Buy |
1,251,208
+279
| +0% | +$27.8K | 0.8% | 22 |
|
|
2019
Q2 | $136M | Buy |
1,250,929
+500,326
| +67% | +$54.6M | 1.05% | 16 |
|
|
2019
Q1 | $83.9M | Sell |
750,603
-1,522
| -0.2% | -$170K | 0.53% | 37 |
|
|
2018
Q4 | $72.5M | Buy |
752,125
+1,573
| +0.2% | +$152K | 0.6% | 39 |
|
|
2018
Q3 | $91.5M | Sell |
750,552
-499,448
| -40% | -$60.9M | 0.53% | 56 |
|
|
2018
Q2 | $137M | Buy |
1,250,000
+100,000
| +9% | +$11M | 0.73% | 27 |
|
|
2018
Q1 | $123M | Buy |
1,150,000
+992,783
| +631% | +$106M | 0.75% | 26 |
|
|
2017
Q4 | $16.8M | Sell |
157,217
-192,783
| -55% | -$20.6M | 0.13% | 160 |
|
|
2017
Q3 | $117M | Buy |
350,000
+297,011
| +561% | +$99.1M | 1.08% | 20 |
|
|
2017
Q2 | $16.4M | Buy |
+52,989
| New | +$16.4M | 0.19% | 126 |
|
|
2017
Q1 | – | Sell |
-150,392
| Closed | -$39.9M | – | 979 |
|
|
2016
Q4 | $39.9M | Buy |
+150,392
| New | +$39.9M | 0.41% | 59 |
|
|
2016
Q1 | – | Sell |
-1,903
| Closed | -$644K | – | 340 |
|
|
2015
Q4 | $644K | Buy |
+1,903
| New | +$644K | 0.01% | 213 |
|